Update shared on04 Aug 2025
Fair value Increased 6.53%Welspun's analyst price target was raised to ₹1087 as the market is assigning a higher earnings multiple despite largely unchanged revenue growth forecasts.
What's in the News
- Board meeting scheduled to consider and approve standalone and consolidated unaudited financial results for the quarter ended June 30, 2025.
- Board meeting scheduled to consider and approve standalone and consolidated audited financial results for the quarter and year ended March 31, 2025.
- Consideration of a final dividend recommendation for the financial year ended March 31, 2025.
- Consideration of fundraising through issuance of Commercial Papers and/or Non-Convertible Debentures on a private placement basis.
Valuation Changes
Summary of Valuation Changes for Welspun
- The Consensus Analyst Price Target has risen from ₹1020 to ₹1087.
- The Future P/E for Welspun has risen from 22.90x to 24.65x.
- The Consensus Revenue Growth forecasts for Welspun remained effectively unchanged, moving only marginally from 24.7% per annum to 24.3% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.